FDA Pitches Off-Label Rules Amid Criticism
The U.S. Food and Drug Administration is looking to clear the way for drug companies to provide doctors with information on off-label uses of prescription drugs, in a proposal that has...To view the full article, register now.
Already a subscriber? Click here to view full article